The attachment protein “spike” of the new coronavirus SARS-CoV-2 uses the same cellular attachment factor (ACE2) as SARS-CoV and uses the cellular protease TMPRSS2 for its activation. Existing, clinically approved drugs directed against TMPRSS2 inhibit SARS-CoV-2 infection of lung cells. Illustration: Markus Hoffmann
Göttingen infection researchers identify potential drug
Viruses must enter cells of the human body to cause disease. For this, they attach to suitable cells and inject their genetic information into these cells. Infection biologists from the German Primate Center – Leibniz Institute for Primate Research in Göttingen, together with colleagues at Charité – Universitätsmedizin Berlin, have investigated how the novel coronavirus SARS-CoV-2 penetrates cells. They have identified a cellular enzyme that is essential for viral entry into lung cells: the protease TMPRSS2. A clinically proven drug known to be active against TMPRSS2 was found to block SARS-CoV-2 infection and might constitute a novel treatment option (Cell).
Several coronaviruses circulate worldwide and constantly infect humans, which normally caused only mild respiratory disease. Currently, however, we are witnessing a worldwide spread of a new coronavirus with more than 90,000 confirmed cases and over 3,000 deaths. The new virus has been named SARS coronavirus-2 and has been transmitted from animals to humans. It causes a respiratory disease called COVID-19 that may take a severe course. The SARS coronavirus-2 has been spreading since December 2019 and is closely related to the SARS coronavirus that caused the SARS pandemic in 2002/2003. No vaccines or drugs are currently available to combat these viruses.
Stopping virus spread
A team of scientists led by infection biologists from the German Primate Centre and including researchers from Charité, the University of Veterinary Medicine Hannover Foundation, the BG-Unfallklinik Murnau, the LMU Munich, the Robert Koch Institute and the German Center for Infection Research, wanted to find out how the new coronavirus SARS-CoV-2 enters host cells and how this process can be blocked. The researchers identified a cellular protein that is important for the entry of SARS-CoV-2 into lung cells. “Our results show that SARS-CoV-2 requires the protease TMPRSS2, which is present in the human body, to enter cells,” says Stefan Pöhlmann, head of the Infection Biology Unit at the German Primate Center. “This protease is a potential target for therapeutic intervention.”
Since it is known that the drug camostat mesilate inhibits the protease TMPRSS2, the researchers have investigated whether it can also prevent infection with SARS-CoV-2. “We have tested SARS-CoV-2 isolated from a patient and found that camostat mesilate blocks entry of the virus into lung cells,” says Markus Hoffmann, the lead author of the study. Camostat mesilate is a drug approved in Japan for use in pancreatic inflammation. “Our results suggest that camostat mesilate might also protect against COVID-19,” says Markus Hoffmann. “This should be investigated in clinical trials.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Detroit mom who beat COVID-19 while battling stage 4 cancer returns home in time for Mother's Dayon May 10, 2020 at 5:46 pm
A Detroit mother of five was hospitalized for 40 days after contracting COVID-19. What makes her survival story so special is not just her fighting spirit, but the fact that she is also battling stage ...
- National coronavirus updates: Pence will not self-quarantine, plans to be at the White House Mondayon May 10, 2020 at 5:42 pm
There have been more than 1.3 million coronavirus cases in the United States, according to the Johns Hopkins University tally . The U.S. death toll has surpassed 79,000 people, according to Hopkins.
- Firefighter encourages reading during COVID-19 quarantineon May 10, 2020 at 5:38 pm
A father and fireman reads with his daughter to encourage kids stuck in quarantine to continue learning despite being out of school.
- Sen. Lamar Alexander to self-quarantine after staff member tests positive for COVID-19on May 10, 2020 at 5:37 pm
Sen. Lamar Alexander (R-Tenn.) will self-quarantine after a staff member tested positive for the coronavirus.
- New Coronavirus Deaths In Florida Decline For Mother's Dayon May 10, 2020 at 5:36 pm
Florida health officials reported fewer deaths from the new coronavirus on Sunday as Floridians celebrated Mother's Day amid restrictions.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- UK launches clinical trial to evaluate new treatments for COVID-19on May 6, 2020 at 6:18 am
Clinical leaders from the University of Kentucky will discuss a new clinical trial to test treatments for patients with COVID-19 in Kentucky. The trial will investigate azithromycin, ivermectin and ...
- One hundred fifty five drugs and 79 vaccines under development worldwideon April 20, 2020 at 7:28 am
A total of 155 drugs and 79 vaccines are currently being developed worldwide to combat COVID-19. The Austrian Institute for Health Technology Assessment (AIHTA) has compiled these astonishing ...
- Could an existing drug help against the new coronavirus?on April 10, 2020 at 10:22 pm
Medical researchers are working hard to find a vaccination against the novel coronavirus. But parallel to these efforts, the repurposing of existing drugs could shorten lengthy clinical trial phases ...
- 35 drugs in the race to treat new coronaviruson March 6, 2020 at 5:20 pm
Camostat mesilate is a drug approved in Japan for use in pancreatic inflammation. "We have tested SARS-CoV-2 isolated from a patient and found that camostat mesilate blocks entry of the virus into ...
- This drug may protect against novel coronavirus: Studyon March 6, 2020 at 12:49 am
Researchers have found a drug called camostat mesylate, that they believe may work to combat the novel coronavirus (COVID-19), which has claimed over 3,000 lives globally, majority of them in ...